Investor relations

Observe Medical is a Nordic medtech company that develops, markets and sells innovative medtech products for the global market. The company is committed to improving patient welfare and outcomes, increasing clinical data accuracy, and promoting positive health economics.

Observe Medical is listed on Euronext Oslo under OBSRV.

Read our latest regulatory news

Observe Medical secures new financing

Oslo, March 23, 2023 – Observe Medical ASA ("Observe Medical" or "the Company") has entered into loan agreements for its short term financing needs. Further to the stock exchange announcement on 14 December 2022, the Company has entered into loan agreements where the lenders have committed to an amount of NOK 10 million. The Company…

Read more

Observe Medical ASA: Fourth quarter 2022 results

Observe Medical ASA: Fourth quarter 2022 results Oslo, 17 February 2023 – Observe Medical ASA (“the Company” or “Observe Medical”) today releases its results for the fourth quarter of  2022. "The year 2022 has been a transformational year for Observe Medical. Building on the growth initiatives seen earlier in the year, we signed two exclusivity…

Read more

Observe Medical provides an update on contemplated financing

Oslo, 14 December 2022 – The Nordic medtech company Observe Medical ASA ("Observe Medical" or "the Company") is planning to issue a NOK 30-50 million bond loan in the first quarter of 2023, which is expected to be followed by a NOK 100-150 million equity issue around mid-year 2023. It is contemplated that the bond…

Read more

Reports and presentations

Financial calendar

  • 17 February 2023

    Quarterly Presentation - Q4 2022

  • 28 April 2023

    Annual Report 2022

  • 26 May 2023

    Annual General Meeting

  • 25 August 2023

    First Half Year 2023 presentation

The Share

Share performance

Shareholders

As at 14 March 2023.

NameNumber of shares% of top 20% of total Country
1INGERØ REITEN INVESTMENT COMPANY AS9,653,680 29.56%18.05%Norway
2NAVAMEDIC ASA4,222,727 12.93%7.89%Norway
3RO, LARS3,340,000 10.23%6.24%Norway
4JPB AS2,830,209 8.66%5.29%Norway
5ELI AS*1,744,260 5.34%3.26%Norway
6MP PENSJON PK1,676,188 5.13%3.13%Norway
7UBS Switzerland AG1,460,413 4.47%2.73%Switzerland
8BJØRNTVEDT, VEGARD809,962 2.48%1.51%Norway
9LAPAS AS805,185 2.47%1.51%Norway
10NORDNET LIVSFORSIKRING AS786,471 2.41%1.47%Norway
11Nordnet Bank AB653,507 2.00%1.22%Sweden
12SILVERCOIN INDUSTRIES AS624,464 1.91%1.17%Norway
13SOLEGLAD INVEST AS586,668 1.80%1.10%Norway
14SKÅLVOLD EIENDOM AS507,513 1.55%0.95%Norway
15TAJ HOLDING AS500,847 1.53%0.94%Norway
16GINNY INVEST AS500,000 1.53%0.93%Norway
17PETTERSEN, GUNERIUS500,000 1.53%0.93%Norway
18TRANBERGKOLLEN INVEST AS500,000 1.53%0.93%Norway
19CAM AS481,000 1.47%0.90%Norway
20BRØDRENE KARLSEN HOLDING AS479,868 1.47%0.90%Norway
Total number owned by top 20 32,662,962 100.00%61.06%
Total number of shares 53,491,656

* Pending transfer to each shareholders VPS account ELI AS has, since the closing af the Biim Ultrasound acquisition in March 2022, held 433,818 shares owned by former shareholders in Biim Ultrasound AS. The transfer of the shares took place on March 14 2023 with the result that ELI’s registered shareholding in Observe Medical have been reduced by the corresponding number of shares.

Basic share data

Stock Exchange:

Ticker:

First day of listing:

Sector:

Trading Currency:

ISIN:

Number of shares issued:

Nominal value:

Euronext Expand Oslo

OBSRV

4 November 2019

Healthcare

NOK

NO0010865009

53 491 656

NOK 0.26

 

Governance

Nomination committee

The Articles of Association provide for a nomination committee composed of two or three members. The current members of the nomination committee are Bård Brath Ingerø (chair) and Grete Hogstad.

The nomination committee is responsible for nominating candidates for the election of shareholder-elected members and chairperson to the Board of Directors and for nominating members to the nomination committee, as well as making recommendations for remuneration of these.

For nomination committee please contact:
Bård Brath Ingerø, Chair of the Nomination Committee
+47 92 83 33 34 / bbi@reitenco.no

2022

3 June 2022: Minutes from Annual General Meeting 2022

3 June 2022: Represented list

31 May 2022: Board of Directors recommendation for appointment of auditor

31 May 2022: The Nomination Committee recommendation part 2

13 May 2022: Notice of Annual General Meeting on 3 June 2022

13 May 2022: Notice of attendance and proxy form to the Annual General Meeting on 3 June 2022

13 May 2022: The Nomination Committee’s recommendation (part 1)

13 May 2022: Guidelines for determination of salary and other remuneration to executive personnel

13 May 2022: Report on salary and other remuneration to executive personnel year 2021

13 May 2022: VPS – Investor services

13 May 2022: LUMI

13 May 2022: Online guide LUMI (Norsk)

13 May 2022: Online guide LUMI (English)

4 February 2022: Minutes from Extraordinary General Meeting
4 February 2022: Represented list
14 January 2022: Notice of Extraordinary General Meeting on 4 February 2022
14 January 2022: Notice of attendance and proxy form to the Extraordinary General Meeting on 4 February 2022

 

2021

21 May 2021: Minutes from Annual General meeting
30 April 2021: Notice of Annual General Meeting on 21 May 2021

30 April 2021: Notice of attendance and proxy form to the Annual General meeting on 21 May 2021

30 April 2021: The Nomination Committee's recommendation

30 April 2021: Guidelines for determination of salary and other remuneration to executive Personnel

 

2020

30 June 2020: Annual General Meeting

16 June 2020: Extraordinary General Meeting

9 June 2020: Notice of Annual General Meeting on 30 June 2020

9 June 2020: Attendance to the Annual General Meeting on 30 June 2020

9 June 2020: Recommendation by the Nomination Committee

9 June 2020: The Boards declaration on remuneration to executive management

26 May 2020: Notice of Extraordinary General Meeting on 16 June 2020

26 May 2020: Attendance to the Extraordinary General Meeting on 16 June 2020

 

2019

24 October 2019: Extraordinary General Meeting

1 October 2019: Extraordinary General Meeting

5 August 2019: Extraordinary General Meeting

IR contact

Rune Nystad, Chief Executive Officer                                                                         +47 91 62 46 83 / rune.nystad@observemedical.com

Per Arne Nygård, Chief Financial Officer                                                              +47 41 10 43 45 / perarne.nygard@observemedical.com

Sign up for the mailing list